You would have to take two 1.0mg injections, which is not cost efficacious. In final draft guidance, published on 8 September 2023, the National Institute for Health and Care Excellence (NICE) recommended tirzepatide for the treatment of T2DM, reversing its initial decision against use of the drug in June 2023
J., Deanfield, J., Garvey, W
[DOI] [Google Scholar] 267.Bianchi V.E., Herrera P.F., Laura R
10.1002/ijc.20636
They are eligible to prescribe GLP-1 drugs with semaglutide or tirzepatide as active ingredients, as well as compounded medications including drugs such as acarbose, orlistat, naltrexone, and others if determined medically appropriate
Its rapid onset makes it preferable to longer-acting opioids for acute procedures such as tracheal intubation and chest tube insertion (82, 86)